Boston, 13 Feb 2023: About 10% of drugs approved by the US Food and Drug Administration (FDA) between 2018 and 2021 had pivotal trials with null findings, according to a research letter published in JAMA Internal Medicine.
 
“Our findings underscore ......
View Details

Related News

• Cystic fibrosis drug could help treat pneumonia: Study (14-03-2023)

---

• Research team of IIT-Roorkee discovers new antibacterial molecule (12-03-2023)

---

• New pill ‘Bempedoic Acid’ cuts cholesterol, heart attacks (06-03-2023)

---

• Drug resistant bacteria secrete toxins: Study (14-02-2023)

---

• Extracts from 2 wild plants can block Covid-19 virus: Study (11-02-2023)

---

• Methotrexate linked to increased risk of three types of skin cancer (08-02-2023)

---

• Japanese Researchers Developing Device To Detect Brain Tumour Through Urine (04-02-2023)

---

• Plant toxin Albicidin hailed as 'new weapon' in antibiotic war against bacteria (30-01-2023)

---

• Gut bacteria affect brain health, mouse study shows (14-01-2023)

---

• A New Weapon Edoxudine Against Antibiotic-Resistant Bacteria (08-01-2023)

---